Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p.

Gao, Ying; Yin, Zheng; Qi, Yunling; Peng, Hong; Ma, Wenbin; Wang, Ruizhi; Li, Wen.

Gao Y; Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Yin Z; Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Qi Y; Division of Vascular Surgery, National Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Peng H; Center of hepato-pancreatobiliary surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Ma W; School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China.
Wang R; Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. wangrzh3@mail.sysu.edu.cn.
Li W; Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. wangrzh3@mail.sysu.edu.cn.

Cancer Cell Int ; 22(1): 35, 2022 Jan 24.

Article en En | MEDLINE | ID: mdl-35073936